Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Weight Gain

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Weight Gain in 7 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research Excerpts

ExcerptRelevanceReference
"3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a powerful releaser of 5-HT and chronic use of this drug can cause depletion of monoamines."1.35Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus. ( Cho, KO; Chung, SY; Kim, SY; Kwack, SJ; Rhee, GS, 2008)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breivik, T1
Bogen, IL1
Haug, KH1
Fonnum, F1
Opstad, PK1
Eide, DM1
Myhre, O1
Cho, KO1
Rhee, GS1
Kwack, SJ1
Chung, SY1
Kim, SY1
Barenys, M1
Gomez-Catalan, J1
Camps, L1
Teixido, E1
de Lapuente, J1
Gonzalez-Linares, J1
Serret, J1
Borras, M1
Rodamilans, M1
Llobet, JM1
Won, L1
Bubula, N1
Heller, A1
Sanchez, V1
Camarero, J1
O'Shea, E1
Green, AR1
Colado, MI1
Achat-Mendes, C1
Anderson, KL1
Itzhak, Y1
Koprich, JB1
Campbell, NG1
Lipton, JW1

Other Studies

7 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Weight Gain

ArticleYear
Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats.
    Neurochemistry international, 2014, Volume: 72

    Topics: Alveolar Bone Loss; Animals; Brain; Brain Chemistry; Disease Progression; Male; N-Methyl-3,4-methyle

2014
Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus.
    Neuroscience, 2008, Jun-26, Volume: 154, Issue:3

    Topics: Animals; Antimetabolites; Astrocytes; Birth Weight; Bromodeoxyuridine; Cell Count; Cell Proliferatio

2008
MDMA (ecstasy) delays pubertal development and alters sperm quality after developmental exposure in the rat.
    Toxicology letters, 2010, Aug-16, Volume: 197, Issue:2

    Topics: Animals; Female; Fertility; Hallucinogens; Hypothalamo-Hypophyseal System; Lactation; Male; N-Methyl

2010
Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture.
    Brain research. Developmental brain research, 2002, Jul-30, Volume: 137, Issue:1

    Topics: Animals; Cell Count; Cells, Cultured; Dopamine; Female; Fetus; Litter Size; Mice; Mice, Inbred C57BL

2002
Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats.
    Neuropharmacology, 2003, Volume: 44, Issue:4

    Topics: Animals; Body Temperature; Brain; Diet; Dopamine; Drug Synergism; Eating; Glutathione Peroxidase; In

2003
Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood.
    Neuropharmacology, 2003, Volume: 45, Issue:1

    Topics: Age Factors; Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Psychological; Male;

2003
Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
    Brain research. Developmental brain research, 2003, Dec-30, Volume: 147, Issue:1-2

    Topics: Animals; Animals, Newborn; Brain Chemistry; Brain Stem; Brain-Derived Neurotrophic Factor; Chromatog

2003